Invite Sabine for a senior clinical leadership voice.
Sabine takes on podcast appearances, conference keynotes, and press interviews where leadership accountability, vendor governance, or partnership integrity is the topic. Not a product pitch. Not a vendor sales pitch. A clinical development executive’s perspective on what actually holds under pressure.
Request a bookingWhy invite Sabine
What hosts and organizers tend to say about booking her on their stage or their show.
Operator, not theorist
Over two decades inside clinical operations, governance design, and sponsor-vendor partnership structures. Examples come from lived pattern recognition, not frameworks borrowed from elsewhere.
Independent voice
Seuss+ is independent of CRO delivery. Sabine can comment on governance and accountability across the sponsor-vendor relationship without a commercial axis.
Prepared, not performative
Sabine prepares with the host or organizer. She shows up with specific, publishable insight, not quotable hot takes. Hosts say she’s “the person you bring in when stakes are high and nuance matters.”
Quotable Sabine
“Execution can be delegated. Responsibility cannot be outsourced.”Foundation POV · Leadership Accountability
“Communication breakdown is not a downstream issue. It is an early leadership failure.”Core POV 01 · Communication + Alignment
“Contracts transfer work. They do not transfer accountability.”Core POV 02 · Accountability Retention
“When vulnerability is punished, reality goes underground.”Core POV 03 · Trust + Transparency
What Sabine speaks to
Four lanes Sabine has developed across years of speaking, writing, and partnership work. Each maps to a published perspective and a repeatable body of examples.
Communication breakdown as a leadership signal
Why busy doesn’t mean aligned, and how early leaders can tell assumption from actual agreement.
Accountability retention in delegated work
What contracts and governance structures actually transfer, and what they never do.
Vulnerability as a trust mechanism
When honesty is penalized, reality goes underground. How to protect it instead.
The patient as the leadership compass
How to re-center patient consequence in the decisions operational pressure tends to crowd out.
Recent appearances

Cut the Chat Life Science InsiderQuality as Culture: Why Biotechs Can’t Afford to Get It Wrong
Quality isn’t just a checkbox — it’s a biotech differentiator. What does “quality” really mean in biotech? And why does it so often get treated…

Cut the Chat Life Science InsiderInnovation, Execution, and Equity in RNA-Based Women’s Health
In this episode, Seuss+ CEO and Co-Founder Sabine Hutchison sits down with Klaas Zuideveld, CEO of Versameb, to discuss the scientific, clinical, and societal implications…

Cut the Chat Life Science InsiderTwo Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)
The Life Science Insider is back with a brand-new video-first format — and this kickoff episode gets real fast. In this raw, unscripted premiere, Seuss+…

Press + media downloads
Approved assets for journalists, podcast producers, and event organizers. All files are current and cleared for publication.
Headshots
Download pack →Full bio
Download PDF →Speaker one-sheet
Download PDF →Seuss+ logos
Download pack →Gina Dunn
For press inquiries, podcast bookings, speaking invitations, and interview requests. Responses within 2 business days.
Book Sabine
Submit your podcast, speaking, or interview request. Include the topic, audience, and timing. Sabine’s team will reply within 2 business days.
Who manages bookings: Gina Dunn, Director of Marketing at Seuss+.
Booking FAQ
How far in advance should I book Sabine?+
For podcasts, 2-4 weeks typical. For conference keynotes and panels, 8-12 weeks ideally. Press interviews on topical stories are often faster turnaround.
Does Sabine charge a speaking fee?+
Fees depend on event type, audience, and whether it’s sponsored programming. Some engagements are unpaid when the platform and audience fit is strong. Include budget context in your request and we’ll reply with whether the fit is right.
What topics will Sabine NOT speak to?+
Sabine does not speak to specific clinical trial outcomes, regulatory predictions, or any topic requiring disclosure of client-confidential information. She also does not participate in vendor rankings or competitive CRO comparisons. All POVs are public-safe and grounded in pattern recognition, not specific cases.
Can Sabine travel for speaking engagements?+
Yes. Sabine is based in Hamburg, Germany, and travels internationally for events. Remote and virtual appearances also supported.
What producers and journalists get when they book Sabine
Sabine Hutchison speaks and writes as an operator, not a commentator. Over two decades inside clinical development — as a scientist, a data leader, and the co-founder of a clinical development partner firm — mean she arrives to interviews with first-person experience of the governance failures, vendor decisions, and leadership patterns she talks about. She translates the operating reality of clinical trials into language a non-technical audience can follow without losing the specifics that matter to practitioners.
She takes a testable point of view. “Trials don’t fail at the site; they fail at the partnership” is not a soundbite for her — it is the argument she will defend on air, with examples, and with the counter-arguments she has already heard from the other side. Producers who want a guest who will commit to a position rather than hedge get a useful episode. Journalists working on a governance, trust, or clinical-oversight angle get a source who can name the mechanisms, not just describe the vibe.
Booking Sabine — what to expect
- Plain-English translation of clinical governance and vendor-sponsor dynamics for non-technical audiences.
- First-person operator experience across Phase I to Phase III biotech and pharma programs.
- A defended, testable point of view on leadership accountability and partnership integrity.
- Based in Hamburg, Germany. Comfortable on European and US time zones. Interviews in English or German.
- Fast to confirm. Two business days to a yes or no, including proposed angles and available dates.
The industry backdrop that frames Sabine’s work
If a journalist or producer is covering clinical development, biotech strategy, or pharma partnerships, the numbers below are the shape of the problem space Sabine works inside. They are why governance and vendor-sponsor trust are not abstract concerns — the cost and complexity of every program amplify the consequences of the structural choices she writes about.
Topics Sabine speaks on
Sabine’s topics cluster around four themes, each with a developed point of view and a body of written work: vendor selection as a leadership decision rather than a procurement exercise, the difference between governance and status reporting, data ownership as trust architecture, and partnership integrity as a leading indicator of program outcome. For formats that need a narrower angle, she will propose a sharper cut of any of these — a regulatory-inspection story, a specific governance-model case, or a leadership-accountability piece on what boards should be asking of their clinical-stage operating teams.
Read more: Recent perspectives for topic angles she is actively writing on, or About Sabine for full bio and speaker credentials.
